U.S. Markets closed
  • S&P 500

    3,851.85
    +52.94 (+1.39%)
     
  • Dow 30

    31,188.38
    +257.86 (+0.83%)
     
  • Nasdaq

    13,457.25
    +260.07 (+1.97%)
     
  • Russell 2000

    2,160.62
    +9.48 (+0.44%)
     
  • Crude Oil

    53.28
    +0.04 (+0.08%)
     
  • Gold

    1,871.30
    +4.80 (+0.26%)
     
  • Silver

    25.94
    +0.17 (+0.68%)
     
  • EUR/USD

    1.2118
    -0.0015 (-0.1212%)
     
  • 10-Yr Bond

    1.0900
    -0.0020 (-0.18%)
     
  • Vix

    21.58
    -1.66 (-7.14%)
     
  • GBP/USD

    1.3669
    +0.0034 (+0.2529%)
     
  • USD/JPY

    103.5500
    -0.3420 (-0.3292%)
     
  • BTC-USD

    35,602.41
    +1,202.44 (+3.50%)
     
  • CMC Crypto 200

    696.42
    -4.19 (-0.60%)
     
  • FTSE 100

    6,740.39
    +27.44 (+0.41%)
     
  • Nikkei 225

    28,523.26
    -110.24 (-0.39%)
     

Abbvie Inc (ABBV) EVP, Commercial Operations Jeffrey Ryan Stewart Sold $2.7 million of Shares

GuruFocus.com
·1 min read

- By insider

EVP, Commercial Operations of Abbvie Inc (30-Year Financial, Insider Trades) Jeffrey Ryan Stewart (insider trades) sold 25,290 shares of ABBV on 12/29/2020 at an average price of $105 a share. The total sale was $2.7 million.


AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. AbbVie Inc has a market cap of $187.74 billion; its shares were traded at around $106.342200 with a P/E ratio of 22.48 and P/S ratio of 4.22. The dividend yield of AbbVie Inc stocks is 4.43%. AbbVie Inc had annual average EBITDA growth of 8.00% over the past ten years. GuruFocus has detected 3 severe warning signs with AbbVie Inc. .

Directors and Officers Recent Trades:

  • EVP, Commercial Operations Jeffrey Ryan Stewart sold 25,290 shares of ABBV stock on 12/29/2020 at the average price of $105. The price of the stock has increased by 1.28% since.

For the complete insider trading history of ABBV, click here

.This article first appeared on GuruFocus.